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ewly synthesized proteins that do not fold correctly
in the ER are targeted for ER-associated protein degra-
dation (ERAD) through distinct sorting mechanisms;
soluble ERAD substrates require ER-Golgi transport and
retrieval for degradation, whereas transmembrane ERAD
substrates are retained in the ER. Retained transmembrane
proteins are often sequestered into specialized ER subdo-
mains, but the relevance of such sequestration to proteasomal
degradation has not been explored. We used the yeast
 
Saccharomyces cerevisiae 
 
and a model ERAD substrate,
the cystic ﬁbrosis transmembrane conductance regulator
(CFTR), to explore whether CFTR is sequestered before
degradation, to identify the molecular machinery regulating
sequestration, and to analyze the relationship between
 
sequestration and degradation. We report that CFTR is
N
 
sequestered into ER subdomains containing the chaperone
Kar2p, and that sequestration and CFTR degradation are
 
disrupted in 
 
sec12
 
ts
 
 strain (mutant in guanine-nucleotide
exchange factor for Sar1p), 
 
sec13
 
ts
 
 strain (mutant in the
Sec13p component of COPII), and 
 
sec23
 
ts
 
 strain (mutant in
the Sec23p component of COPII) grown at restrictive temper-
ature. The function of the Sar1p/COPII machinery in CFTR
sequestration and degradation is independent of its role in
ER-Golgi trafﬁc. We propose that Sar1p/COPII-mediated
sorting of CFTR into ER subdomains is essential for its entry
into the proteasomal degradation pathway. These ﬁndings
reveal a new aspect of the degradative mechanism, and
suggest functional crosstalk between the secretory and the
degradative pathways.
 
Introduction
 
Quality control of newly synthesized membrane proteins occurs
in the ER (Ellgaard and Helenius, 2001). Incorrectly folded
proteins are targeted for ER-associated protein degradation
(ERAD)* and are eliminated by the ubiquitin-proteasome
pathway (Brodsky and McCracken, 1999). Because protea-
somal degradation occurs in the cytoplasm, ERAD substrates
must be retrotranslocated from the ER to the cytoplasm before
digestion. The cellular machinery involved in the sorting
and translocation of ERAD substrates is under active investi-
gation. One of the key requirements is a fully competent
early secretory pathway because mutations in proteins involved
in ER-Golgi traffic cause disorganization of ER structure
and inhibit ERAD (Taxis et al., 2002). The Sec61p/Sec63p
translocon (Plemper et al., 1997) and auxiliary proteins
Der1p (Knop et al., 1996), Der3p/Hrd1p (Bordallo and
Wolf, 1999), and Hrd3 (Hampton et al., 1996) have been
shown to be required for retrotranslocation of ERAD sub-
strates. In addition, a subset of molecular chaperones such as
calnexin (McCracken and Brodsky, 1996), BiP (Plemper et
al., 1997; Nishikawa et al., 2001), Hsp70 (Zhang et al., 2001),
and p97 (Rabinovich et al., 2002) participate in selecting
ERAD substrates. Evidence indicates that two distinct
mechanisms participate in directing different substrates for
ERAD (Vashist et al., 2001). Soluble ERAD substrates such
as carboxy peptidase Y (CPY), PrA, and KHN require func-
tional transport between the ER and the Golgi (Caldwell et
al., 2001; Vashist et al., 2001), and the degradation of these
proteins is delayed when ER-Golgi traffic is inhibited in
 
sec18
 
–
 
1
 
 and 
 
sec12
 
–
 
4
 
 strains. Additional components encoded
by 
 
PER17
 
 (Vashist et al., 2001), 
 
ERV14
 
, and 
 
ERV29 
 
(Caldwell
et al., 2001) appear essential in degradation of soluble
ERAD substrates, and appear to function by regulating ER-
Golgi transport of specific soluble proteins. In contrast, the
degradation of membrane ERAD substrates such as mutant
forms of Ste6p, Yor1p, Sec61p, Vph1p, and cystic fibrosis
transmembrane conductance regulator (CFTR) seem unaf-
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fected by 
 
sec18
 
–
 
1
 
,
 
 sec12
 
–
 
4
 
,
 
 sec21
 
–
 
1
 
,
 
 per17
 
–
 
1
 
,
 
 erv14
 
 
 
, or
 
erv29
 
 
 
 mutations (Loayza et al., 1998; Katzmann et al.,
1999; Caldwell et al., 2001; Kiser et al., 2001; Vashist et al.,
2001). These findings suggest that transmembrane ERAD
substrates do not enter post-ER compartments of the secre-
tory pathway before degradation. In agreement, soluble
ERAD substrates can be detected in post-ER transport vesi-
cles, whereas transmembrane ERAD substrates are excluded
(Vashist et al., 2001).
The exact pathway for degradation of transmembrane
ERAD substrates from the ER is unclear, but there is evi-
dence to suggest that at least some retained proteins are
sorted into specialized ER subdomains before degradation
(Kamhi-Nesher et al., 2001; Kiser et al., 2001; Zhang et al.,
2001). It is unknown what molecular mechanisms regulate
sequestration of ERAD substrates, and whether such seques-
tration is required for ER retrotranslocation and proteaso-
mal degradation. To explore these questions, we used the
yeast 
 
Saccharomyces cerevisiae
 
 and mutant strains defective in
the Sar1p/COPII sorting machinery and a known ERAD
substrate, CFTR, as our model system.
Sar1p/COPII-mediated selection of ER proteins for secre-
tory traffic is one of the best understood mechanisms for se-
lective recruitment of proteins in the ER (Antonny and
Schekman, 2001). COPII sorting is initiated by Sar1p, a
small GTPase (Veldhuisen et al., 1997) that is activated by
Sec12p-mediated guanine-nucleotide exchange. Sar1p in its
GTP-bound state associates with the ER membrane and re-
cruits the Sec23p/Sec24p–COPII complex and subsequently
the Sec13p/Sec31p–COPII complex to the membrane (for
review see Barlowe, 2000). The assembly of the COPII coat
on ER budding structures is coupled to the selection of
transmembrane proteins into the nascent budding structures
that will eventually bud from the ER as transport vesicles.
COPII function has been examined to date exclusively in
the context of secretory traffic.
CFTR is a chloride channel present on the apical surface
of epithelial cells lining the respiratory, intestinal, and exo-
crine tissues (Kirk, 2000). In mammalian cells, only 
 
 
 
20%
of newly synthesized wild-type CFTR folds correctly and is
transported from the ER to the plasma membrane through
the secretory pathway, whereas the remaining 
 
 
 
80% of
CFTR is degraded from the ER through the ubiquitin-pro-
teasome pathway (Jensen et al., 1995; Ward et al., 1995;
Moyer et al., 1998; Riordan, 1999). In mammalian cells,
CFTR is not sequestered into ER subdomains before degra-
dation because inhibition of proteasomal activity by chemi-
cal inhibitors or overtaxing the proteolytic capacity by over-
expressing CFTR leads to retrotranslocation of CFTR from
the ER and its accumulation in cytosolic aggresomes
(Johnston et al., 1998). In yeast, the majority (if not all) of
newly synthesized CFTR is also degraded through the ubiq-
uitin-proteasome pathway, but in contrast to mammalian
cells, CFTR in yeast is not delivered to aggresomes, but ap-
pears sequestered in ER subdomains before degradation
(Kiser et al., 2001; Zhang et al., 2001).
Here, we report that the Sar1p/COPII machinery func-
tions in sorting CFTR into ER subdomains before proteaso-
mal degradation, and that such sorting is required for CFTR
entry into the degradative pathway. This function of Sar1p/
 
COPII does not involve ER-Golgi traffic. Our results sup-
port a model in which the Sar1p/COPII machinery partici-
pates in sorting proteins to both the anterograde secretory
pathway and the degradative pathway. These findings raise
the possibility that all newly synthesized proteins are sub-
jected to a Sar1p/COPII sorting mechanism, irrespective of
their ultimate secretory or degradative fate.
 
Results and discussion
 
GFP-tagged CFTR is a bona-fide ERAD substrate 
in yeast
 
To provide a substrate for our studies, we generated a con-
struct containing EGFP fused in frame to the NH
 
2
 
 terminus
of human CFTR in a yeast expression vector under a cop-
per-inducible promoter. As shown in Fig. 1 A, EGFP-CFTR
Figure 1. EGFP-CFTR represents yeast ERAD substrate. (A) Yeast 
transformed with pCU426CUP1 (EGFP-CFTR,   lane) or 
pCU426CUP1/EGFP-CFTR (EGFP-CFTR,   lanes) were induced, 
labeled with [
35S]methionine for 20 min, and lysed. Lysates were 
immunoprecipitated with anti-CFTR, anti-F1 , or anti-GFP pAbs. 
A band of 175 kD, appropriate for a chimera of EGFP and CFTR, 
can be immunoprecipitated with anti-CFTR and anti-GFP antibodies 
from cells expressing EGFP-CFTR. (B) Wild-type, pre1–1, and 
ubc6  yeast were transformed with pCU426CUP1/EGFP-CFTR, 
induced, and pulse-labeled with [
35S]methionine for 20 min. An 
equal amount of culture was taken at each chase time, lysed, and 
the lysates were immunoprecipitated with anti-CFTR antibody. 
Relative intensities of EGFP-CFTR bands were quantitated. EGFP-
CFTR is stabilized in pre1–1 and ubc6  strains.T
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is detected after immunoprecipitation with anti-CFTR anti-
body and anti-GFP antibody after copper induction of wild-
type yeast carrying the EGFP-CFTR plasmid (Fig. 1 A,
lanes 1 and 4), but not from yeast carrying an empty vector
(Fig. 1 A, lane 3). EGFP-CFTR is not seen in a sample pre-
cipitated with anti-F1
 
 
 
 antibody. The mobility of EGFP-
CFTR (
 
 
 
175 kD) is appropriate for a chimera of EGFP
(
 
 
 
27 kD) and full-length human CFTR (
 
 
 
145 kD).
To ensure that EGFP-CFTR behaves as an ERAD sub-
strate, we examined its degradation rate in mutant strains
lacking either a functional proteasome subunit (
 
pre1
 
–
 
1
 
) or
an ubiquitin-conjugation enzyme (
 
ubc6
 
 
 
). Both proteins
have been previously shown to be required for degradation
of CFTR tagged at the COOH terminus with GFP (Kiser et
al., 2001) or HA (Zhang et al., 2001) in yeast. As shown in
Fig. 1 B, EGFP-CFTR in wild-type yeast is digested rapidly,
with a half-life of 
 
 
 
10–15 min (Fig. 1 B), slightly more rap-
idly than previously published (
 
 
 
20 min, Kiser et al., 2001;
 
 
 
30 min, Zhang et al., 2001). All CFTR appears to be de-
graded in yeast (Kiser et al., 2001; Zhang et al., 2001), as
opposed to mammalian cells where 
 
 
 
20% is transported to
the plasma membrane. It is possible that yeast does not have
sufficient machinery to efficiently fold overexpressed CFTR,
or that even correctly folded CFTR is “read” by yeast as de-
fective. In contrast to rapid degradation in wild-type yeast,
EGFP-CFTR remains stable in 
 
pre1
 
–
 
1
 
 mutant yeast even af-
ter 90 min of chase, and the half-life of EGFP-CFTR in the
 
ubc6
 
 
 
 strain is extended to 
 
 
 
40 min. Because our EGFP-
CFTR construct is degraded through the ubiquitin-protea-
some pathway in yeast, we use it as an ERAD substrate to
test Sar1p/COPII involvement in proteasomal targeting.
 
EGFP-CFTR is sorted to subcompartments 
of ER before degradation
 
Previous studies have shown that CFTR tagged at the
COOH terminus with GFP (Kiser et al., 2001) or HA
(Zhang et al., 2001) is degraded as an integral membrane
protein and colocalizes with the ER chaperone Kar2p in
punctate ER structures before degradation. To analyze our
EGFP-CFTR construct, we first tested its association with
membranes. As shown in Fig. 2 A, EGFP-CFTR is detected
exclusively in the membrane pellet fraction after medium
speed centrifugation, indicating that it is degraded as a
membrane-associated form.
We performed immunofluorescence with known organel-
lar markers to localize EGFP-CFTR. As shown in Fig. 2 B,
EGFP-CFTR is not detected in small punctate structures
containing the late Golgi marker Kex2p (Preuss et al.,
1992). This result agrees with findings that CFTR expressed
in yeast undergoes ER-type 
 
N
 
-glycosylation, but does not
Figure 2. EGFP-CFTR localization depends on 
functional Sar1p/COPII machinery. (A) Yeast 
expressing EGFP-CFTR was subjected to membrane 
fractionation. A sample of each fraction was 
processed by SDS-PAGE, transferred to nitrocellulose 
membrane, and immunoblotted with anti-CFTR 
antibody. T; total lysate. S; supernatant after high 
speed centrifugation. P1, P2, P3; pellets after low 
speed, medium speed, and high speed centrifugation, 
respectively. EGFP-CFTR is recovered exclusively 
in the membrane fraction. (B) Wild-type yeast 
expressing EGFP-CFTR was grown to log phase and 
processed for immunofluorescence using anti-Kar2p 
or anti-Kex2p antibodies, or was incubated with the 
fluorescent dye FM 4–64 for 45 min at 0 C, followed 
by 1 h at 24 C to stain the vacuole. EGFP-CFTR 
colocalizes only with the ER marker Kar2p. (C) Wild-
type yeast transformed with pCU426CUP1 (  EGFP-
CFTR) or with pCU426CUP1/EGFP-CFTR (  EGFP-
CFTR) was grown to log phase, induced, and 
processed for immunofluorescence with anti-Kar2p 
antibodies (insets) and for electron microscopy. 
Kar2p shows typical ER localization in   EGFP-CFTR 
cells, but distributes to punctate structures in 
  EGFP-CFTR cells. Cells without EGFP-CFTR 
contain normal ER (arrows), but cells expressing 
EGFP-CFTR show accumulation of membranous 
elements (arrowheads). Bar, 0.5  m. (D) Wild-type, 
ubc6 , sec18–1
ts, and sec23–1
ts yeast transformed 
with pCU426CUP1/EGFP-CFTR was grown to log 
phase and induced at permissive (24 C) or restrictive 
(39 C) temperature. Live yeast were then imaged by 
fluorescence microscopy. EGFP-CFTR localizes to 
ER subdomains in wild-type, ubc6 , and sec18–1
ts 
yeast grown at permissive or restrictive temperatures. 
EGFP-CFTR localizes to ER subdomains in sec23–1
ts 
yeast grown at permissive temperature, but is 
diffusely distributed throughout the ER in sec23–1
ts 
yeast grown under restrictive temperature.T
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undergo Golgi-type oligosaccharide modifications (Kiser et
al., 2001). EGFP-CFTR is not detected on the plasma
membrane, and does not colocalize with the fluorescent dye
FM 4–64 (Fig. 2 B) shown to be transported to endosomal
(unpublished data) or vacuolar compartments of yeast as a
function of incubation time and temperature (Vida and
Emr, 1995; the minimal colocalization in the vacuole is due
to bleed-through from the strong EGFP-CFTR signal and is
not visible in cells without EGFP-CFTR). The lack of vacu-
olar localization is consistent with lack of degradation of
CFTR via the Pep4p/Prb1p vacuolar proteases (Kiser et al.,
2001; Gelman et al., 2002).
EGFP-CFTR is detected in relatively large punctate struc-
tures that contain Kar2p (Fig. 2 B). The punctate Kar2p dis-
tribution in EGFP-CFTR–expressing yeast is distinct from
its normal cage-like perinuclear localization in control yeast
(Paddon et al., 1996). The effects of EGFP-CFTR expres-
sion on intracellular morphology were analyzed by electron
microscopy of yeast transformed with either empty or
EGFP-CFTR–containing plasmids. As shown in Fig. 2 C,
normal nuclear membrane and sub–plasma membrane ER
structures are evident in the control cell (arrows), in agree-
ment with published images (Zhang et al., 2001). In con-
trast, EGFP-CFTR cell shows clusters of membranous struc-
tures in proximity to the perinuclear ER (arrowheads).
Higher magnification shows them to be accumulations of tu-
bular and vesicular elements, morphologically analogous to
ER extensions observed in yeast expressing CFTR (Zhang et
al., 2001). The relative size of such clusters (average diameter
 
 
 
0.5–1 
 
 
 
m) corresponds to the approximate size of the flu-
orescent Kar2p/EGFP-CFTR puncta. Significantly, mem-
brane amplification induced by CFTR (Zhang et al., 2001)
or EGFP-CFTR (this work) is distinct from multi-layered
ER “karmellae” induced by expression of HMG-CoA reduc-
tase (Koning et al., 1996). Together, the data suggest that
EGFP-CFTR localizes to subdomains of the ER network
that represent penultimate stations before degradation. The
results also imply that sequestration into the ER domains is
more efficient than subsequent removal by degradation.
 
Functional Sar1p/COPII machinery is required for 
sorting EGFP-CFTR to ER subdomains
 
To determine if the Sar1p/COPII machinery participates in
sorting EGFP-CFTR, we examined its localization when
COPII function is disrupted. First, we tested the localization
of EGFP-CFTR in wild-type, 
 
ubc6
 
 
 
, and 
 
sec18
 
–
 
1
 
 yeast
strains when grown at 24
 
 
 
C (permissive temperature for
strains defective in COPII components) and when grown at
39
 
 
 
C (restrictive temperature for strains defective in COPII
components). As shown in Fig. 2 D, EGFP-CFTR in the
wild-type strain remains as punctate spots at both tempera-
tures. Similarly, the pattern of EGFP-CFTR in the 
 
ubc6
 
 
 
strain defective for proteasomal degradation is analogous to
that in the wild-type strain. This strongly suggests that
EGFP-CFTR is sorted into the punctate structure and
maintained there before it is targeted for ubiquitination and
degradation. Our data, together with the finding that CFTR
remains sequestered in Kar2p-containing subdomains in
yeast strain (
 
pre1
 
–
 
1pre2
 
–
 
2
 
) defective for proteasomal degra-
dation (Zhang et al., 2001), suggest that the catalytic activity
 
of ubiquitin-conjugating enzyme Ubc6p is not sufficient to
remove EGFP-CFTR from ER subdomains, and that ubiq-
uitination and proteasomal degradation are tightly coupled.
The same punctate EGFP-CFTR pattern is observed in
 
sec18
 
–
 
1
 
 strain grown at either temperature, indicating that
block in vesicular fusion during ER-Golgi protein transport
does not significantly affect EGFP-CFTR sequestration.
Analysis of EGFP-CFTR localization in the 
 
sec23
 
–
 
1
 
ts
 
strain (Kuehn et al., 1998) showed significant temperature-
dependent changes (Fig. 2 D). At the permissive tempera-
ture, EGFP-CFTR is sequestered into ER subdomains, but
at the restrictive temperature, EGFP-CFTR is diffusely dis-
tributed throughout the ER in a pattern characteristic of ER
proteins (compare enlargement with Kar2p staining in inset;
Fig. 2 C). Similar results were obtained when yeast strains
mutant in other components of the Sar1p/COPII machin-
ery (described below) were analyzed (unpublished data).
 
Functional Sar1p/COPII machinery is required
for EGFP-CFTR degradation
 
To uncover whether the Sar1p/COPII machinery is also in-
volved in CFTR degradation, we compared the degradation
rate of EGFP-CFTR at permissive (24
 
 
 
C) and restrictive
(39
 
 
 
C) temperature in yeast mutant in Sar1p/COPII com-
ponents. In wild-type strain, EGFP-CFTR is degraded rap-
idly at both temperatures, with a half-life of 10–15 min (Fig.
3 A). The temperature-sensitive strain, 
 
sec12–4
 
ts
 
, is defective
in catalyzing GDP/GTP exchange on Sar1p at the restrictive
temperature due to a P73L mutation (Barlowe and Schek-
man, 1993). EGFP-CFTR is degraded rapidly in the 
 
sec12
 
–
 
4
ts strain at permissive temperature; with a half-life ( 10
min) analogous to that in wild-type strain (Fig. 3 B). In con-
trast, the degradation rate is delayed significantly when the
yeast is shifted to the restrictive temperature, with the half-
life extending to 40–45 min, a threefold increase compared
with the permissive temperature. The temperature-sensitive
strains sec23–1
ts and sec13–1
ts (Salama et al., 1997) are defec-
tive at the restrictive temperature due to an S382L mutation
(Yoshihisa et al., 1993), and a mutation that has not yet
been identified, respectively. In both cases, COPII function
is compromised. EGFP-CFTR is degraded rapidly in both
sec23–1
ts and sec13–1
ts strains at the permissive temperature,
with half-lives of  15 min (Fig. 3, C and D). In contrast,
the degradation rates are significantly delayed in both strains
at the restrictive temperatures, with a half-life of  50 min.
The significant inhibition of EGFP-CFTR degradation sug-
gests that functional COPII machinery is required for pro-
teasomal degradation of EGFP-CFTR.
It must be stressed that EGFP-CFTR, like other trans-
membrane ERAD substrates, does not enter the ER-Golgi
recycling degradative pathway. Like the previously charac-
terized CFTR (Kiser et al., 2001), EGFP-CFTR is degraded
with normal kinetics at permissive and restrictive tempera-
tures in a sec18–1 strain (Fig. 3 E). The strain is defective in
Sec18p function, as shown by a block in maturation of the
vacuolar CPY at the restrictive temperature (Fig. 3 E). To-
gether, the results indicate that ER-Golgi transport and recy-
cling are not required for EGFP-CFTR degradation. Our
findings suggest a novel role for the Sar1p/COPII sorting
machinery. In addition to selecting correctly folded sub-T
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strates into the forward secretory pathway (Schekman and
Orci, 1996; Bannykh et al., 2000) and selecting misfolded
soluble ERAD substrates for the ER-Golgi recycling degra-
dative pathway (Vashist et al., 2001), Sar1p/COPII also
sorts misfolded substrates into subdomains of the ER from
which they are subsequently degraded. How does the same
machinery sort proteins into three distinct pathways? A
common sorting mechanism for both correctly folded and
misfolded membrane proteins presents a spatial problem be-
cause these classes must occupy distinct regions of the ER. It
is likely that additional targeting mechanisms coordinate
with Sar1p/COPII to direct the proteins to ER exit or reten-
tion. It appears that a primary distinction is made at the
level of packaging into COPII vesicles; although correctly
folded soluble and transmembrane proteins for secretory
traffic and misfolded soluble ERAD substrates for ER-Golgi
recycling degradative traffic are sorted into COPII vesicles,
misfolded transmembrane ERAD substrates are excluded
(Vashist et al., 2001). There is evidence that transmembrane
ERAD substrates are prevented from entry into COPII vesi-
cles and are retained in the ER through the action of luminal
ER proteins. For example, mutants of the transmembrane
ATPase Pma1p appear to be retained and degraded in the
ER through the action of a protein disulfide isomerase–
related protein, Eps1p (Wang and Chang, 1999). Similarly,
the retention of a transmembrane H2a precursor in the ER
is determined by a pentapeptide sequence present on the lu-
minal side of the ER (Shenkman et al., 1997). In addition,
ERAD substrates can be retained by binding to calnexin. It
has been shown that calnexin binds to wild-type and folding
compromised  F508CFTR in the ER, but the association
with  F508CFTR is prolonged and might facilitate ER re-
tention (Pind et al., 1994). ERAD substrates can be also re-
tained by association with the translocon (Loayza et al.,
1998; Kamhi-Nesher et al., 2001). Cytoplasmic chaperones
may also participate in ER retention (Brodsky et al., 1999).
The finding that strains inactivated in the cytosolic Hsp70
Ssa1p do not sort CFTR into ER subdomains supports the
view that ER sequestration requires the coordinate action of
Sar1p/COPII and accessory factors.
That Sar1p/COPII is likely to participate in the secretory
and the degradative pathways is supported by data obtained
from whole genome microarray analysis where many genes in-
volved in secretory traffic were found to be UPR targets
(Travers et al., 2000). Initially, the up-regulation was viewed as
means to increase traffic in the ER-Golgi recycling degradative
pathway for soluble ERAD substrates (Caldwell et al., 2001).
However, our work suggests that the up-regulation is also a
means to increase components required for ER sequestration
of transmembrane ERAD substrates. Specifically relevant to
our analysis is the up-regulation of SEC12, SEC13, and
SEC24. Thus, it may be that the UPR-mediated up-regulation
of these genes may not be a cellular strategy to remove protein
from the ER by exporting them, but additionally might pro-
mote sorting of retained proteins toward degradation.
Materials and methods
Antibodies and plasmids
Anti-CFTR NBD1 pAb was described previously (Bebok et al., 1998) and
was a gift from Dr. David Bedwell (University of Alabama at Birmingham,
Birmingham, AL). Anti-Kar2p pAb was a gift from Dr. Jeffrey Brodsky (Uni-
versity of Pittsburgh, Pittsburgh, PA). Anti-Kex2p mAb was a gift from Dr.
Vytas Bankaitis (University of North Carolina at Chapel Hill, Chapel Hill,
NC). Anti–COOH-terminal CFTR mAb was purchased from USBiological.
Anti-CPY antibody was purchased from Molecular Probes, Inc. Goat anti–
rat and anti–mouse antibodies conjugated with fluorescein isothiocyanate
or rhodamine were purchased from Jackson ImmunoResearch Laboratories.
To generate an inducible construct expressing GFP-tagged CFTR in
yeast, pEGFP-CFTR plasmid (Moyer et al., 1998) was first digested with
SacII, and then treated with Klenow fragment followed by digestion with
NheI. The pRSETB/EGFP plasmid (provided by Dr. David Bedwell) was
first digested with HindIII and then treated with Klenow fragment followed
by digestion with NheI. The EGFP-containing fragment from pRSETB/EGFP
and CFTR-containing fragment from pEGFP-CFTR were gel-purified, li-
gated, and transformed into Eschericia coli. The resulting plasmid was then
digested with NheI and EcoRV, and treated with Klenow fragment. The
EGFP-CFTR–containing fragment was gel-purified and cloned into the
Figure 3. EGFP-CFTR degradation depends on functional 
Sar1p/COPII machinery. Wild-type (A), sec12–4
ts (B), sec23–1
ts (C), 
sec13–1
ts (D), and sec18–1
ts (E) yeast were transformed with 
pCU426CUP1/EGFP-CFTR. Yeast were grown to log phase and 
induced at permissive temperature. An equal amount of culture was 
then pulse-labeled with [
35S]methionine for 20 min at either 24 C or 
39 C. An equal amount of culture was taken after indicated chase 
times and used to prepare cell lysates. Lysates were immuno-
precipitated with anti-CFTR or anti-CPY (for sec18–1
ts) antibody. 
Relative intensities of EGFP-CFTR bands were quantitated. EGFP-CFTR 
degradation is significantly inhibited by inactivation of Sec12p, 
Sec23p, and Sec13p.T
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SmaI site of pCU426CUP1 (Labbe and Thiele, 1999). The final construct
was sequenced to ensure the correct open reading frame.
Yeast strains 
CTY182 (MATa, ura3–52,  his3–200, lys2–80), CTY252 (MATa, ura3–52,
sec12–4
ts), CTY253 (MATa, ura3–52, sec13–1
ts), and CTY260 (MAT ,
ura3–52, leu2–3, 112, sec23–1
ts) were a gift from Dr. Vytas Bankaitis.
YHI29/W (MATa, ura3, leu2–3, 112, his3–11, 15, cans, GAL1), YHI29/1
(MATa, pre1–1, ura3, leu2–3, 112, his3–11, 15, cans, GAL1), and
YWO0346 (MAT , ura3–1, leu2–3, 112, his3–11, 15, ade2–1 ocre, trp1–1,
can1–100, ubc6::LEU2) were a gift from Dr. Dieter Wolf (Universitat Stutt-
gart, Stuttgart, Germany). SEY6210 (MAT  ura3–52 leu2–3, 112 his3- 200
trp1- 901 lys2–801 suc2- 9) and SEY5186 (MAT  sec18–1 ura3–52
leu2–3, 112 GAL
 ) were a gift from Dr. David Bedwell.
Yeast media were prepared as described previously (Rose et al., 1990).
Unless specified, in all experiments, cultures were grown for a minimum
of 5–6 generations to an A600 of no more than 1.0.
Fractionation, immunofluorescence, and electron microscopy
Yeast expressing EGFP-CFTR was fractionated as described previously
(Paddon et al., 1996). In brief, cells grown to exponential phase were con-
verted to spheroplasts using yeast lytic enzyme (ICN Biomedicals) in the
presence of 20 mM potassium phosphate buffer, pH 7.0, and containing
1.2 M sorbitol. The spheroplasts were washed and disrupted using a
Dounce homogenizer in 25 mM Hepes-NaOH buffer, pH 7.4, plus pro-
tease inhibitors (Sigma-Aldrich). Cell lysates were centrifuged at 4 C at 500 g
for 10 min, and the resulting supernatant was spun at 25,000 g for 15 min.
The resulting supernatant was centrifuged at 150,000 g for 1 h. Pellet from
each spin was washed with Hepes buffer and saved as P1, P2, and P3, re-
spectively. Protein concentration was measured using a Detergent Com-
patible Protein Assay kit (Bio-Rad Laboratories).
For immunofluorescent studies, yeast were grown in synthetic complete
medium lacking uracil to an OD600 of no more than 1.0. Yeast were fixed
by adding formaldehyde to 3% and incubating at either 24 C or 39 C for
30 min. Cells were harvested and washed twice with 0.1 M potassium
phosphate, pH 6.5, and once with potassium phosphate buffer containing
1.2 M sorbitol. The cell walls were digested by adding  -mercaptoethanol
to 0.1% and zymolase 20T (U.S. Biological) to 20  g/ml. After incubating
at 30 C for 1 h, cells were washed twice with sorbitol buffer, applied to
polylysine-coated coverslips, and were allowed to settle at RT for 20 min.
The cells were refixed with 3% formaldehyde for 5 min followed by
quenching with 50 mM of NH4Cl for 5 min. Cells were permeabilized with
0.1% Triton X-100 for 10 min and washed twice for 5 min each with
blocking buffer (PBS containing 0.2% Tween 20 and 1 mg/ml BSA). Cells
were incubated overnight with primary antibody diluted 1:5,000 for anti-
Kar2p antibody and 1:2,000 for anti-Kex2p antibody. Coverslips were
washed three times with blocking buffer. Cells were incubated with sec-
ondary antibody for 1 h and washed as above. Coverslips were mounted
on slides in 9:1 glycerol/PBS with 0.1% p-phenylenediamine. Images were
acquired with an inverted microscope (Axiovert 30; Carl Zeiss MicroImag-
ing Inc.). IpLab Spectrum software (Signal Analytics Corp.) was used to
control image acquisition.
Yeast containing either an empty plasmid or EGFP-CFTR–containing
plasmid were grown to an A600 of  0.5, induced with copper for 2 h, and
processed for electron microscopy as described previously (Kaiser and
Schekman, 1990). Grids were examined on an electron microscope
(model 100CX; JEOL USA, Inc.).
Pulse-chase labeling and immunoprecipitation
Yeast were grown overnight to log phase at 24 C in synthetic complete
medium supplemented with appropriate amino acids. EGFP-CFTR expres-
sion was induced with 100  M of CuSO4 for 2 h (Labbe and Thiele, 1999).
A total of 32 OD600 U of cells was harvested (3 OD600 U for each time
point) and resuspended in 4 ml synthetic complete medium plus 100  M
CuSO4. Each culture was separated into two parts and was incubated with
shaking at 24 C or 39 C for 10 min. Cells were then labeled with 200  Ci
of [
35S]methionine (Trans
35S label from ICN Biomedicals) for 20 min. The
label was chased with 40  l of chasing mixture (1 mg/ml methionine, 1
mg/ml cysteine, and 15% yeast extract). 0.4-ml samples were collected at
0, 15, 30, 60, and 90 min and added to 25  l of 100% TCA (5% final TCA
concentration). Samples were mixed, placed on ice for 20 min, and
washed twice with ice-cold acetone. Cells were resuspended in lysis buffer
(50 mM Tris-HCl, pH 7.5, 0.5% SDS, and protease inhibitors) and broken
down by vortexing with glass beads. EGFP-CFTR was immunoprecipitated
from total cell lysate using a polyclonal anti-NBD1 CFTR antibody (1:250
dilutions). Immunoprecipitates were separated on 6% SDS-PAGE and ana-
lyzed by PhosphorImager (Molecular Dynamics, Inc.). EGFP-CFTR signal
was quantified using ImageQuant Software (Molecular Dynamics, Inc.),
and relative amounts were calculated and plotted using Excel software
(Microsoft). For CPY analysis, pulse-chase was done as above, and lysates
were immunoprecipitated with anti-CPY antibodies. Immunoprecipitates
were resolved on 10% SDS-PAGE and analyzed as above.
SDS-PAGE and immunoblotting
Samples were resolved on 6% SDS-PAGE as described previously (Bebok
et al., 1998). Some gels were electrotransferred to nitrocellulose mem-
brane and immunoblotted with anti–COOH-terminal CFTR mAb as de-
scribed previously (Bebok et al., 1998).
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